#Vaccine Delivery

[unopenablebox]

TRIUMPHS OF TODAY: went on a little walk to buy 🌸 a bubble tea & not only was able to provide them with a refreshing drink that revived them after a running-induced collapse of exhaustion but also caused them to learn that peach + rose flavored tea is extraordinarily delicious and appealing

then we sat around on a picnic blanket in the park by our apartment and read books for like three and a half hours

[libraryspectre]

Huh i drew Bill on my ice bucket at work (i have other little monsters and spooky things drawn on it and he fit in well) and i didnt consider how funny it was to do that in a lab. Especially since when it's not in use it sits on a little shelf over my desk, watching everyone work

I did think I was running the risk of a delivery or maintenance guy posting on conspiracy boards about the lab having ties to the illuminati

[sonicaspeed123]

Pain

[wholelife-pharmacy-healthfoods]

Flu Vaccination: Why It's Vital in Australia?

 The flu, also known as influenza, is a respiratory infection affecting the nose, throat, and lungs caused by a virus. Most people contract it by inhaling airborne droplets from someone else's coughs or sneezes. This disease can cause severe illness and even death, and due to its constantly evolving strains, it is crucial to get a chemist flu vaccination annually to protect oneself and others.

How did the flu come about?

The flu is a respiratory virus with symptoms like fever, nasal congestion, headaches, coughs, muscle aches, sore throat, and exhaustion. It is highly contagious and can be severe, resulting in thousands of deaths in Australia each year. The flu and COVID-19 can have similar symptoms, and it is important to find a pharmacy online for your flu medication and stay at home until you recover. Influenza evolves and mutates, and some strains may be more severe in certain age groups.

Why is getting vaccinated the best way to avoid the flu?

Every year, individuals over six months of age should receive the influenza vaccine to prevent illness and reduce the virus's spread. The vaccine is updated annually to boost immunity against common strains. So, if you are the one who has influenza symptoms, just book your flu medicine delivery Brisbane from your nearby chemist. 

[mitalipingale]

https://sparktv.net/read-blog/36345_vaccine-delivery-devices-market-size-overview-share-and-forecast-2031.html

The Vaccine Delivery Devices Market in 2023 is US$ 4.59 billion, and is expected to reach US$ 9.63 billion by 2031 at a CAGR of 9.70%.

[ralfmaximus]

The discovery represents a potential new way to recruit the immune system to fight treatment-resistant cancers using an iteration of mRNA technology and lipid nanoparticles, similar to COVID-19 vaccines, but with two key differences: use of a patient’s own tumor cells to create a personalized vaccine, and a newly engineered complex delivery mechanism within the vaccine.

Within 48 hours, the four human study participants showed remarkable results: their immune systems went into turbo cancer-destroying mode. And without surgery, radiation, or dangerous chemotherapy.

Folks, we may have a cure for cancer within your lifetime.

[wintermage]

hate that my brain is so bad at its job that i can't even decide whether to get something delivered for dinner or go to the grocery store and make something without a two hour long deliberation, but also glad that this decision making process is no longer as complicated by the Rampant, Deadly Virus as it once was

[jessicapinedaw]

Vaccine Delivery Devices Market Size, Share, Trends, Analysis and Regional Forecast to 2031

The Insight Partners is excited to announce the release of groundbreaking findings in its latest market research report, “Overview of Vaccine Delivery Devices Market Share, Size, and Forecast | 2031″. The panoramic research, conducted by our team of seasoned experts, provides valuable insights on the Vaccine Delivery Devices market forecast, key trends, drivers, challenges, and opportunities…

[sighphi]

Another factor boosting market growth is the expansion of vaccination and immunization campaigns run by governments and public health groups....

[lago-morpha]

as someone born into a bad situation with someone who had things wrong with them personally & genetically that they passed onto me! I cannot say I am against fully voluntary eugenics for both myself and others

[wilwheaton]

Scientists at UC Riverside have demonstrated a new, RNA-based vaccine strategy that is effective against any strain of a virus and can be used safely even by babies or the immunocompromised.  Their flu vaccine will also likely be delivered in the form of a spray, as many people have an aversion to needles. “Respiratory infections move through the nose, so a spray might be an easier delivery system,” Hai said. Additionally, the researchers say there is little chance of a virus mutating to avoid this vaccination strategy. “Viruses may mutate in regions not targeted by traditional vaccines. However, we are targeting their whole genome with thousands of small RNAs. They cannot escape this,” Hai said. Ultimately, the researchers believe they can ‘cut and paste’ this strategy to make a one-and-done vaccine for any number of viruses. “There are several well-known human pathogens; dengue, SARS, COVID. They all have similar viral functions,” Ding said. “This should be applicable to these viruses in an easy transfer of knowledge.”

Vaccine breakthrough means no more chasing strains

This is HUGE. This will fundamentally change how we get inoculated.

[howdoesone]

How does one ensure equitable access to vaccines globally?

The COVID-19 pandemic has highlighted the importance of equitable access to vaccines as a global health imperative. Ensuring that vaccines are available to all individuals, regardless of their geographical location or socioeconomic status, is crucial for controlling the spread of infectious diseases and achieving global health security. This article explores the challenges in achieving equitable…

[mitalipingale]

The Vaccine Delivery Devices Market in 2023 is US$ 4.59 billion, and is expected to reach US$ 9.63 billion by 2031 at a CAGR of 9.70%.

[reasonsforhope]

"Engineers at the University of Pennsylvania have made a critical breakthrough that promises better outcomes for pregnancies threatened with pre-eclampsia, a condition that arises due to insufficient blood flow to the placenta, resulting in high maternal blood pressure and restricted blood flow to the fetus.

Pre-eclampsia is one of the leading causes of stillbirths and prematurity worldwide, and it occurs in 3 to 5% of pregnancies. Without a cure, options for these patients only treat symptoms, such as taking blood pressure medication, being on bed rest, or delivering prematurely—regardless of the viability of their baby.

Making a decision to treat pre-eclampsia in any manner can be a moral conundrum, to balance many personal health decisions with long-standing impacts—and for Kelsey Swingle, a doctoral student in the UPenn bioengineering lab, these options are not enough.

In previous research, she conducted a successful proof-of-concept study that examined a library of lipid nanoparticles (LNPs)—which are the delivery molecules that helped get the mRNA of the COVID vaccine into cells—and their ability to reach the placenta in pregnant mice.

In her latest study, published in Nature, Swingle examined 98 different LNPs and their ability to get to the placenta and decrease high blood pressure and increase vasodilation in pre-eclamptic pregnant mice.

Her work shows that the best LNP for the job was one that resulted in more than 100-fold greater mRNA delivery to the placenta in pregnant mice than an FDA-approved LNP formulation.

The drug worked.

“Our LNP was able to deliver an mRNA therapeutic that reduced maternal blood pressure through the end of gestation and improved fetal health and blood circulation in the placenta,” says Swingle.

“Additionally, at birth we saw an increase in litter weight of the pups, which indicates a healthy mom and healthy babies. I am very excited about this work and its current stage because it could offer a real treatment for pre-eclampsia in human patients in the very near future.”

While further developing this cure for pre-eclampsia and getting it to the market for human use is on the horizon for the research team, Swingle had to start from scratch to make this work possible. She first had to lay the groundwork to run experiments using pregnant mice and determine how to induce pre-eclampsia in this animal model, processes that are not as well studied.

But, by laying this groundwork, Swingle’s work has not only identified an avenue for curing pre-eclampsia, it also opens doors for research on LNP-mRNA therapeutics addressing other reproductive health challenges...

As Swingle thinks ahead for next steps in her research, which was funded by the National Institutes of Health and the National Science Foundation, she will also collaborate to further optimize the LNP to deliver the mRNA even more efficiently, as well as understanding the mechanisms of how it gets to the placenta, a question still not fully answered.

They are already in talks about creating a spin-off company and want to work on bringing this LNP-mRNA therapeutic to clinical trials and the market.

Swingle, who is currently finishing up her Ph.D. research, has not only successfully led this new series of studies advancing pre-eclampsia treatment at Penn, she has also inspired other early career researchers in the field as she continues to thrive while bringing women’s health into the spotlight."

-via Good News Network, December 15, 2024